General Motors Co (NYSE:GM) stock is surging to record highs, last seen up 9.1% at $86.66, after the company's better-than-expected fourth-quarter earnings of $2.51 per share, though revenue of $45.29 billion came in slightly below estimates. The auto name also announced a 20% dividend increase, a $6 billion share repurchase program, and strong 2026 earnings guidance. GM has been rallying on the charts since its early-April lows, now up 57.8% year-over-year. The shares are pivoting higher after consolidatin ...

Core Viewpoint - Barclays has increased its price target for Sandisk, indicating that the stock is experiencing rapid growth that outpaces analysts' ability to adjust their estimates [1] Group 1 - Barclays' new price target reflects a bullish outlook on Sandisk's stock performance [1] - The stock's rise suggests strong market demand and positive investor sentiment towards Sandisk [1] - Analysts are struggling to keep up with the pace of Sandisk's stock appreciation [1]

Core Insights - Critical Metals (NASDAQ: CRML) has experienced a significant surge of 115% in its stock price so far in 2026, indicating strong market performance early in the year [1] Company Performance - The stock price increase of 115% suggests a robust investor interest and potential positive sentiment surrounding Critical Metals [1] Market Trends - The early performance of Critical Metals may reflect broader trends in the critical metals industry, which could be influenced by factors such as demand for electric vehicles and renewable energy technologies [1]

Core Viewpoint - Oracle shares finished 2025 with respectable, market-beating gains, up around 17%, outperforming the S&P 500 by close to a full percentage point [1] Summary by Relevant Categories - **Company Performance** - Oracle's stock increased by approximately 17% in 2025 [1] - The performance surpassed the S&P 500 index by nearly one percentage point [1]

Core Insights - Axsome Therapeutics Inc's stock is experiencing significant gains, rising 19% to $177.13 after the FDA granted priority review for its Alzheimer's disease agitation drug AXS-05 [1] - Analysts from Needham and TD Cowen have reiterated "buy" ratings, with Needham increasing its price target from $154 to $169 [1] - The stock is on track for its largest single-day percentage gain since February, reaching a record peak of $178.99 [2] Stock Performance - If current gains are maintained, Axsome Therapeutics is projected to finish 2025 with over 100% year-to-date gain [2] - The options market has seen a surge, with AXSM's options volume reaching ten times its average daily volume, particularly in the January 2026 185-strike call [2] Short Interest - A portion of the stock's increase may be due to short covering, as short interest accounts for 6.8% of the stock's available float [3] - It would take over five days for short sellers to buy back their borrowed shares based on the stock's average trading pace [3]

Core Insights - XPeng stock price has shown stability within a narrow range over recent months, indicating investor focus on revenue growth and the overall health of the Chinese electric vehicle (EV) sector [1] - The stock is currently trading at $23, reflecting a significant increase of 105% from previous levels, suggesting positive market sentiment towards the company [1]

Core Viewpoint - Beyond Meat, Inc. (Nasdaq: BYND) has experienced a significant surge in premarket trading, with shares increasing by 67% before the market opened [1] Company Summary - The stock of Beyond Meat is one of the top performers in premarket trading, indicating strong investor interest and potential positive sentiment towards the company [1]

Core Insights - Robinhood's stock price has experienced a significant uptrend this year, reaching an all-time high of $129.67, which represents a 229% increase from its starting point [1] Company Performance - The stock price surge indicates strong growth momentum for Robinhood, suggesting positive market sentiment and investor confidence in the company's future prospects [1]

Core Insights - The IREN stock price has experienced a significant increase this year, rising from a low of $5.17 in April to $47 today [1] - This surge in stock price has resulted in a substantial increase in market capitalization, growing from approximately $1 billion to over $12.7 billion [1]

Core Insights - Nio's stock price has experienced a significant increase, reaching a high of $7, marking its highest level since October of the previous year [1] - The stock has surged by 133% year-to-date, reflecting strong investor interest in Chinese technology companies [1] Company Summary - Nio's stock performance indicates a robust recovery and investor confidence in the company's future prospects [1] - The increase in stock price aligns with a broader trend of investment in the Chinese technology sector, suggesting a favorable market environment for companies like Nio [1]